Antidepressant-like and anxiolytic-like effects of hydrogen sulfide in streptozotocin-induced diabetic rats through inhibition of hippocampal oxidative stress

Depression is highly prevalent in individuals with diabetes, and depressive symptoms are less responsive to current antidepressant therapies. Oxidative stress plays a major role both in the pathogenesis of diabetes and in major depression and anxiety disorders. Hydrogen sulfide (H2S), the third gaseous mediator, is a novel signaling molecule in the brain that has both antioxidative activity and antidepressant-like and anxiolytic-like effects. We hypothesized that H2S could produce antidepressant-like and anxiolytic-like effects in diabetic patients through its antioxidative effect. To test this hypothesis, we generated streptozotocin (STZ)-induced diabetic rats. We found that H2S alleviated depressive-like behaviors of STZ-induced diabetic rats in the forced swimming and tail suspension tests and reduced their anxiety-like behaviors in the elevated plus maze test. We also found that H2S significantly reduced levels of malondialdehyde and 4-hydroxynonenal and elevated levels of superoxide dismutase and reduced glutathione in the hippocampus of STZ-induced diabetic rats. The results provide evidence for antidepressant-like and anxiolytic-like effects of H2S in STZ-induced diabetic rats and suggest that the therapeutic effects may result from inhibition of hippocampal oxidative stress. These findings suggest that elevating H2S signaling is a potential target for treatment of depressive and anxiety disorders related to diabetes.

[1]  J. Kamei,et al.  Abnormal benzodiazepine receptor function in the depressive-like behavior of diabetic mice , 2005, Pharmacology Biochemistry and Behavior.

[2]  Zhi-Sheng Jiang,et al.  Hydrogen Sulfide, the Next Potent Preventive and Therapeutic Agent in Aging and Age-Associated Diseases , 2013, Molecular and Cellular Biology.

[3]  B. Halliwell,et al.  The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite ‘scavenger’? , 2004, Journal of neurochemistry.

[4]  P. Corcoran,et al.  Anxiety and depression symptoms in patients with diabetes , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[5]  S. Agrawal.  Role of self- Care in management of diabetes mellitus. , 2016, The Journal of the Association of Physicians of India.

[6]  C. Szabó.  Roles of hydrogen sulfide in the pathogenesis of diabetes mellitus and its complications. , 2012, Antioxidants & redox signaling.

[7]  J. Bocchini,et al.  Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation? , 2010, Antioxidants & redox signaling.

[8]  P. Wong,et al.  Hydrogen sulfide: A novel signaling molecule in the central nervous system , 2010, Neurochemistry International.

[9]  Yi-Zhun Zhu,et al.  Hydrogen sulfide attenuates lipopolysaccharide-induced cognitive impairment: A pro-inflammatory pathway in rats , 2010, Pharmacology Biochemistry and Behavior.

[10]  Jianhua Li,et al.  Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammation in beta-amyloid rat model of Alzheimer’s disease , 2012, Journal of Neuroinflammation.

[11]  J. Gu,et al.  Contribution of neural cell death to depressive phenotypes of streptozotocin-induced diabetic mice , 2014, Disease Models & Mechanisms.

[12]  B. Thierry,et al.  The tail suspension test: A new method for screening antidepressants in mice , 2004, Psychopharmacology.

[13]  B. Frey,et al.  Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder , 2012, Oxidative medicine and cellular longevity.

[14]  Michael Rickels,et al.  Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants , 1995, Psychopharmacology.

[15]  D. Dardevet,et al.  Lipid peroxidation and antioxidant status in experimental diabetes. , 1999, Clinica chimica acta; international journal of clinical chemistry.

[16]  M. Galantucci,et al.  Hydrogen sulfide slows down progression of experimental Alzheimer’s disease by targeting multiple pathophysiological mechanisms , 2013, Neurobiology of Learning and Memory.

[17]  Jie Zhao,et al.  Exogenous hydrogen sulfide protects against global cerebral ischemia/reperfusion injury via its anti-oxidative, anti-inflammatory and anti-apoptotic effects in rats , 2013, Brain Research.

[18]  H. Heymans,et al.  Health-related quality of life, anxiety and depression in young adults with disability benefits due to childhood-onset somatic conditions , 2013, Child and Adolescent Psychiatry and Mental Health.

[19]  A. Ceriello,et al.  Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemia. , 1999, Metabolism: clinical and experimental.

[20]  F. Liu,et al.  Adiponectin is critical in determining susceptibility to depressive behaviors and has antidepressant-like activity , 2012, Proceedings of the National Academy of Sciences.

[21]  G. Rajkowska,et al.  Decreased Expression of Synapse-Related Genes and Loss of Synapses in Major Depressive Disorder , 2012, Nature Medicine.

[22]  S. File,et al.  Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat , 1985, Journal of Neuroscience Methods.

[23]  R. Beck,et al.  Depression in Adults in the T1D Exchange Clinic Registry , 2014, Diabetes Care.

[24]  J. Bian,et al.  Hydrogen sulfide regulates intracellular pH in rat primary cultured glia cells , 2010, Neuroscience Research.

[25]  J. Calvert,et al.  Novel insights into hydrogen sulfide--mediated cytoprotection. , 2010, Antioxidants & redox signaling.

[26]  I. Lucki.  The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. , 1997, Behavioural pharmacology.

[27]  M. Werner,et al.  Increased oxidative stress in prefrontal cortex and hippocampus is related to depressive-like behavior in streptozotocin-diabetic rats , 2014, Behavioural Brain Research.

[28]  P. Moore,et al.  Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain? , 2005, Biochemical and biophysical research communications.

[29]  A. Walf,et al.  The use of the elevated plus maze as an assay of anxiety-related behavior in rodents , 2007, Nature Protocols.

[30]  J. Bian,et al.  Hydrogen sulfide: neurophysiology and neuropathology. , 2011, Antioxidants & redox signaling.

[31]  E. Fuchs,et al.  Experimental animal models for the simulation of depression and anxiety , 2006, Dialogues in clinical neuroscience.

[32]  G. King,et al.  The role of oxidative stress in the onset and progression of diabetes and its complications: asummary of a Congress Series sponsored byUNESCO‐MCBN, the American Diabetes Association and the German Diabetes Society , 2001, Diabetes/metabolism research and reviews.

[33]  I. Shim,et al.  Chronic Administration of Catechin Decreases Depression and Anxiety-Like Behaviors in a Rat Model Using Chronic Corticosterone Injections , 2013, Biomolecules & therapeutics.

[34]  P. Moore,et al.  Hydrogen sulphide regulates calcium homeostasis in microglial cells , 2006, Glia.

[35]  K. Abe,et al.  The possible role of hydrogen sulfide as an endogenous neuromodulator , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  山本 順一郎.  Distribution of hydrogen sulfide (H[2]S)-producing enzymes and the roles of H[2]S donor sodium hydrosulfide in diabetic nephropathy , 2012 .

[37]  Maurizio Fava,et al.  Diagnosis and definition of treatment-resistant depression , 2003, Biological Psychiatry.

[38]  Y. Goto,et al.  The FASEB Journal express article 10.1096/fj.04-1815fje. Published online May 20, 2004. Hydrogen sulfide protects neurons from oxidative stress , 2022 .

[39]  O. Shaker,et al.  Role of sulfurous mineral water and sodium hydrosulfide as potent inhibitors of fibrosis in the heart of diabetic rats. , 2011, Archives of biochemistry and biophysics.

[40]  MA Patel,et al.  Possible Role of Hydrogen Sulfide in Insulin Secretion and in Development of Insulin Resistance , 2010, Journal of young pharmacists : JYP.

[41]  K. Freedland,et al.  The prevalence of comorbid depression in adults with diabetes: a meta-analysis. , 2001, Diabetes care.

[42]  Y. Nagai,et al.  Hydrogen sulfide induces calcium waves in astrocytes , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  M. Bekaroǧlu,et al.  Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. , 2001, Journal of affective disorders.

[44]  Rui Wang,et al.  Hydrogen sulfide: the third gasotransmitter in biology and medicine. , 2010, Antioxidants & redox signaling.

[45]  I. Lucki,et al.  Depressive phenotypes evoked by experimental diabetes are reversed by insulin , 2012, Physiology & Behavior.

[46]  R. Porsolt,et al.  Rodent Models of Depression: Forced Swim and Tail Suspension Behavioral Despair Tests in Rats and Mice , 2011, Current protocols in neuroscience.

[47]  A. Juozulynas,et al.  Prevalence and determinants of anxiety and depression symptoms in patients with type 2 diabetes in Lithuania , 2014, Medical science monitor : international medical journal of experimental and clinical research.

[48]  J. Baynes,et al.  Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. , 1999, Diabetes.

[49]  A. Rossi,et al.  Pattern of Comorbidity Among Anxious and Odd Personality Disorders: The Case of Obsessive-Compulsive Personality Disorder , 2000, CNS Spectrums.

[50]  O. Franco,et al.  Bidirectional association between depression and type 2 diabetes mellitus in women. , 2010, Archives of internal medicine.

[51]  M. Katz,et al.  Problems with the differentiation of anxiety and depression. , 1989, Journal of psychiatric research.

[52]  J. Bian,et al.  Effect of hydrogen sulfide on intracellular calcium homeostasis in neuronal cells , 2010, Neurochemistry International.

[53]  Markus K. Muellner,et al.  Hydrogen Sulfide Scavenges the Cytotoxic Lipid Oxidation Product 4-HNE , 2010, Neurotoxicity Research.

[54]  D. Iosifescu.  Treating depression in the medically ill. , 2007, The Psychiatric clinics of North America.

[55]  J. Kamei,et al.  Antidepressant-like effect of leptin in streptozotocin-induced diabetic mice , 2007, Pharmacology Biochemistry and Behavior.

[56]  M. Pollack,et al.  Pharmacotherapeutic Options in the Treatment of Comorbid Depression and Anxiety , 2000, CNS Spectrums.

[57]  I. Hovatta,et al.  Oxidative stress in anxiety and comorbid disorders , 2010, Neuroscience Research.

[58]  Rui Wang.  Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[59]  M. Berk,et al.  A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[60]  J. Denollet,et al.  Anxiety predicted premature all-cause and cardiovascular death in a 10-year follow-up of middle-aged women. , 2009, Journal of clinical epidemiology.

[61]  J. Watkins,et al.  Diabetes, oxidative stress, and antioxidants: A review , 2003, Journal of biochemical and molecular toxicology.

[62]  P. Wong,et al.  Hydrogen Sulfide Inhibits Rotenone-Induced Apoptosis via Preservation of Mitochondrial Function , 2009, Molecular Pharmacology.

[63]  R. Porsolt,et al.  Behavioral despair in mice: a primary screening test for antidepressants. , 1977, Archives internationales de pharmacodynamie et de therapie.

[64]  J. Chen,et al.  Effect of hydrogen sulphide on beta-amyloid-induced damage in PC12 cells. , 2008, Clinical and experimental pharmacology & physiology.